Insider Transaction Report for Dow Geoffrey S

2026-06-15SEC Filing 4 (0001213900-26-068853)

This filing details a transaction by Dow Geoffrey S, President and CEO of 60 DEGREES PHARMACEUTICALS, INC. On June 12, 2026, Mr. Dow acquired 7,350 shares of the company's Common Stock at a price of $1.3784 per share. Following this transaction, Mr. Dow directly owns 24,131 shares of Common Stock. The transaction was reported on Form 4, indicating an insider transaction.